TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023 16:03 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023 16:02 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options
June 15, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 25, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
May 19, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical...
TELA Bio Reports First Quarter 2023 Financial Results
May 11, 2023 16:02 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
May 09, 2023 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023 16:30 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...